The offshore wind technology developer raised the capital from corporates Schlumberger, Eon and Shell and plans to develop a pilot system in 2017.

The Illumina-backed company has raised additional funding after becoming the first company to sequence multiple human genomes using portable technology.

The IP investment firm, which advises universities on spinouts in exchange for equity stakes, has signed its second deal in Portugal.

The Imperial Innovations-backed cancer treatment developer secured $10m from Bristol-Myers to test two drugs to be used in combination.

University venturing fund Oxford Sciences Innovation has added an additional $290m to its assets as spinout Oxford Nanopore attracts another $126m in funding.

The spinout has raised additional funding after announcing earlier this month that it had become the first company to sequence multiple human genomes using portable technology.

Sussex spinout Enterprise Therapeutics, a developer of treatments for respiratory diseases, has secured capital from return investor Imperial Innovations.

The corporate's $100bn Vision Fund, which is reportedly set to be oversubscribed, has opened its head office in the UK and has hired 10 people so far.

FoodPanda backer Rocket Internet will increase its stake in another food delivery platform, Delivery Hero, to almost 38% through the acquisition.

Germany-based consumer-focused debt platform raises funding.